Shepherd Financial Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-9,867
Closed -$886K 138
2018
Q1
$886K Sell
9,867
-2,001
-17% -$192K 0.22% 57
2017
Q4
$1.24M Sell
11,868
-6,753
-36% -$762K 0.29% 47
2017
Q3
$2.59M Sell
18,621
-3,392
-15% -$462K 0.6% 31
2017
Q2
$2.9M Sell
22,013
-3,928
-15% -$481K 0.71% 27
2017
Q1
$3.23M Sell
25,941
-203
-0.8% -$24.3K 0.84% 23
2016
Q4
$3.1M Buy
+26,144
New +$2.91M 0.88% 22

Other funds holding CELG

Shepherd Financial Partners's CELG Position: Q2 2018 in Review

Shepherd Financial Partners sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 9,867 shares — an estimated $886K sold.

Shepherd Financial Partners first reported a position in CELG in Q4 2016 and held it in 6 quarters. The position peaked at $3.23M in Q1 2017. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • Shepherd Financial Partners reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
  • Shepherd Financial Partners sold 9,867 Celgene Corp shares in Q2 2018, an estimated $886K.
  • Shepherd Financial Partners first reported a position in Celgene Corp in Q4 2016 and held it in 6 quarters.
  • Shepherd Financial Partners's Celgene Corp position peaked at $3.23M in Q1 2017.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on Shepherd Financial Partners's 13F filing for Q2 2018, filed 2 Aug 2018.